SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-009773
Filing Date
2015-02-17
Accepted
2015-02-17 12:27:08
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q v400048_10q.htm 10-Q 336033
2 EXHIBIT 31.1 v400048_ex31-1.htm EX-31.1 9892
3 EXHIBIT 31.2 v400048_ex31-2.htm EX-31.2 9903
4 EXHIBIT 32.1 v400048_ex32-1.htm EX-32.1 4898
5 EXHIBIT 32.2 v400048_ex32-2.htm EX-32.2 4851
  Complete submission text file 0001144204-15-009773.txt   5008839

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT antb-20141231.xml EX-101.INS 595027
7 XBRL TAXONOMY EXTENSION SCHEMA antb-20141231.xsd EX-101.SCH 59115
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20141231_cal.xml EX-101.CAL 39668
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20141231_def.xml EX-101.DEF 306493
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20141231_lab.xml EX-101.LAB 388156
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20141231_pre.xml EX-101.PRE 344979
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 15619940
SIC: 2834 Pharmaceutical Preparations